Beacon Cytokine

Maximize Your Data With the Most Complete Trial, Drug, and Commercial Database for Cytokine Therapies

What We Cover

Beacon Cytokine covers clinical trial and drug records for clinical, preclinical, approved and discontinued cytokine-related therapies. The database includes all cytokines and drugs that target a cytokine or its immediate receptor belonging to the following families:

  • Interleukins (ILs)
  • Interferons (IFNs)
  • Colony stimulating factors (CSFs)
  • Transforming growth factor β (TGF-β)
  • Tumor necrosis factor (TNF)
  • Chemokines

The database covers all disease indications (oncology and non-oncology) and all therapeutic classes to provide a complete, detailed and multi-dimensional landscape of the cytokine space.

New data expansionDeals and Companies. Gain unparalleled access to in-depth company profiles and the latest commercial deals. Monitor your competitors and opportunities as well as benchmark deals and evaluate potential partners. Learn more about Deals and Companies data by downloading the factsheet.

How Beacon Helps

Here are some examples of how Beacon Cytokine can accelerate your research programs:

  • Search for cytokine drugs across all stages of development so you can accurately benchmark your strategies against other preclinical and clinical drugs, and investigate the novel approaches used by competitors.
  • Drastically reduce time spent looking through publications and conference abstracts for clinical trial results by relying on our comprehensive collection of data which can be searched by disease, combination treatments and much more.
  • Stay on top of emerging trends and new players in the field with real-time updates and alerts, as well as in-depth monthly reports curated by our expert analyst team.

How Beacon Cytokine Works

Search the trial and drug landscape by cytokine class and method of molecular engineering alongside other search criteria including disease, target, therapeutic class, developer, plus more to instantly extract the data points you need to conduct more complex analyses.

Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the cytokine space.

How We Target the Data

We house all publicly available sources of data updated within 24 – 48 hours of publication proactively.  Our sources cover (but are not limited to):

  • Clinical trials registries
  • Scientific journals and publications
  • Company reports and presentations
  • Press releases
  • Conference reports and abstracts
  • Government and regulatory organizations
  • Newspapers and other media
  • Patents

Related Content

Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization

Find out more

The 2023 Cytokine Landscape Review

Find out more

Cytokine: ESMO Congress 2023 Abstracts

Find out more

What Our Customers Say

Beacon is a great database that people should pay attention to. It's much better than many of the more generic databases that try to capture all data about everything

Director
Top Biotech Company

Our Cytokine Expert

Fatima Hayat is the lead research analyst for cytokine-based drugs and trials in the Beacon team.

Sign up to her weekly newsletter to uncover the latest insights and updates in the cytokine landscape using data from Beacon Cytokine.

Subscribe to Our Cytokine Newsletter

Other Beacon Solutions

ADC
Bispecific
Cancer Vaccine
Cell Therapy
Checkpoint
DDR
Gene Therapy
Immune Tolerance
Microbiome
Oncolytic Viruses
RNA
TPD
Beacon ADC logo 2023

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Bispecific Logo

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

 

Beacon Cell Therapy covers genetically and non-genetically engineered allogeneic and autologous cell-based therapies across all disease indications

Find out more

Beacon Checkpoint Logo

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more

Beacon DDR Logo

 

Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo

 

From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering all therapeutics aimed at treating immune-mediated diseases – Beacon Immune Tolerance provides drug developers with detailed views of the expanding immune tolerance landscape.

Find out more

 

Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon TPD Logo

 

Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

Any Questions? Contact Us

To learn how Beacon Cytokine can align, optimize, and maximize your trial, drug, and commercial intelligence, get in touch with our sales team.

 Harvey Dennis

Cytokine Account Manager

Contact Us

About Beacon

Beacon is a world-leading data analysis subscription platform for drug, trial, and commercial intelligence. With unrivaled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information that gives you the confidence to progress your targeted drug therapies to patients.

logo